Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2046 Neoplasms 1460 Carcinoma, Non-Small-Cell Lung 1363 Prostatic Neoplasms 1106 Multiple Myeloma 872 Leukemia, Myeloid, Acute 772 Colorectal Neoplasms 713 Neoplasm Metastasis 704 Lung Neoplasms 697 Melanoma 688 Lymphoma 666 Leukemia 596 Lymphoma, Non-Hodgkin 593 Leukemia, Lymphocytic, Chronic, B-Cell 535 Ovarian Neoplasms 535 Pancreatic Neoplasms 500 Precursor Cell Lymphoblastic Leukemia-Lymphoma 485 Recurrence 474 Myelodysplastic Syndromes 425 Lymphoma, Follicular 418 Carcinoma, Renal Cell 412 Head and Neck Neoplasms 408 Glioblastoma 380 Lymphoma, Large B-Cell, Diffuse 379 Brain Neoplasms 376 Hodgkin Disease 354 Carcinoma, Hepatocellular 333 Squamous Cell Carcinoma of Head and Neck 326 Lymphoma, Mantle-Cell 306 Sarcoma 286

Interventions

glembatumumab vedotin 1 CR011-vcMMAE 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Squamous Cell Carcinoma of the Lung × Clear all

NCT02713828 2019-07-16

PrE0504

PrECOG, LLC.

Phase 1/2 Terminated

13 enrolled 12 charts

Squamous Cell Carcinoma of the Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡